Pharmaceutical Technology

OCTOBER 6, 2022

from the US National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) to develop a prophylactic intranasal vaccine against Neisseria gonorrhoeae (NG). This trial will evaluate the safety of the vaccine and generate efficacy data. Intravacc has received a contract worth $14.6m

Vaccination 147

Vaccination Vaccine Development Bacterium 147

Scienmag

MARCH 11, 2021

A new clinical study has shown that supplements of a lactic acid bacterium may have positive effects by increasing the diversity of intestinal bacteria in these infants. Extremely preterm infants can suffer from a life-threatening inflammation of the gut.

Bacteria 72

Bacteria Bacterium Research Clinical Trials 72

XTalks

JANUARY 20, 2021

However, IBS patients do not have allergies to any given foods, nor any gastrointestinal conditions, such as celiac disease. Importantly, the immune response was only triggered in the portion of the intestine that had been infected by the bacteria. Moreover, the response did not induce symptoms typical of a food allergy.

Immune Response 52

Immune Response Research Allergies Protein 52

XTalks

AUGUST 2, 2023

2) Botox Therapeutic/Cosmetic Botox, or botulinum neurotoxin, is a neurotoxic protein produced by the Clostridium botulinum bacteria. Clinical trials have shown that the vaccine is 90 percent effective in preventing shingles for individuals aged 50 and over. AbbVie’s total global revenue for Humira was $21.24 billion in 2022.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

XTalks

DECEMBER 24, 2020

As of November, the WHO has discouraged the use of the drug as the agency’s review of data from four different clinical trials yielded no worthy effect on mortality, need for mechanical ventilation, time to clinical improvement or any other important patient outcomes. Vaccine Considerations. CRISPR Therapeutics.

Life Science 111

Life Science Vaccination Vaccine Gene 111